1. Intravenous Streptokinase in Acute Myocardial Infarction Study Group. A prospective trial of intravenous steptokinase in acute mvocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days;N Engl J Med,1986
2. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarcto Miocardico. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
3. International Study of Infarct Survival Steering Committee. Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2;Lancet,1987
4. Thrombolytic therapy in patients with acute myocardial infarction;Rentrop, K.;Circulation,1985
5. Topol EJ, George BS, e al. Are adjuvant therapies needed when t-PA is used? Summary of TAMI 1, II, and III trials;Califf, R.M.;J Am Coll Cardiol,1988